Health Care News and Research

RSS

Prescribing generic heart medications in Medicare Part D could result in substantial savings

Prescribing generic medications for heart and blood vessel diseases more frequently instead of brand-name medications in Medicare's prescription drug program, called Part D, could save more than $600 million each year in the U.S., according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

9 Dec 2021

Never mind toys, it’s time to ask Santa for crutches and catheters

America's hospitals, strained by nearly two years of fighting the covid-19 pandemic, are now scrounging for basic medical supplies.

9 Dec 2021

Health experts worry CDC’s covid vaccination rates appear inflated

For nearly a month, the Centers for Disease Control and Prevention's online vaccine tracker has shown that virtually everyone 65 and older in the United States — 99.9% — has received at least one covid vaccine dose.

9 Dec 2021

COVID-19 led to increased depression and anxiety among urban, ethnic minority children

New research has determined that the first year of the COVID-19 pandemic led to increased depression, anxiety and social risks among urban, racial, and ethnic minority children aged five to 11 years old compared to the prior six months.

9 Dec 2021

Abortion remains safe after removing restrictions on the medical abortion pill, study finds

Abortion remains safe after Canada removed restrictions on the medical abortion pill mifepristone in November 2017.

9 Dec 2021

Youths did not seek healthcare both before and during the COVID-19 pandemic

New study results show that although healthcare access patterns among youth were similar before and during the pandemic, COVID-19 has added some new barriers to seeking medical care when needed.

9 Dec 2021

COVID-19 disruptions linked to increase in malaria cases and deaths

New data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.

8 Dec 2021

New hormone may play a key role in the development of type 1 and type 2 diabetes

A newly discovered hormone named fabkin helps regulate metabolism and may play an important role in the development of both type 1 and type 2 diabetes, according to research led by the Sabri Ülker Center for Metabolic Research at Harvard T.H. Chan School of Public Health.

8 Dec 2021

Impact of COVID-19 on children with complex underlying medical conditions

A new study concludes that children with medical complexities experienced adverse health outcomes during the COVID-19 pandemic.

8 Dec 2021

Optimizing the treatment of epilepsy patients

Researchers have devised a new diagnostic model to predict how generalized epilepsy patients will respond to drug treatment.

8 Dec 2021

Post-pandemic, what’s a phone call from your physician worth?

Maybe this has happened to you recently: Your doctor telephoned to check in with you, chatting for 11 to 20 minutes, perhaps answering a question you contacted her office with, or asking how you're responding to a medication change.

8 Dec 2021

Oncology doctors say the build back better act will slash cancer care funding — a skewed argument

“An independent analysis shows that payments for cancer care will be slashed by close to 45% causing cancer clinics to close and massively raising your healthcare costs”

8 Dec 2021

New projects aim to identify new solutions to combat antimicrobial-resistant infections

Researchers at Washington University School of Medicine in St. Louis will lead projects aimed at identifying new solutions to help prevent antimicrobial-resistant infections and their spread.

8 Dec 2021

Study analyzes the contribution of AI to cancer patient care and vaccine design

Artificial Intelligence/Machine Learning (AI/ML) is the development of computer systems that are able to perform tasks that would normally require human intelligence. AI/ML is used by people every day, for example, while using smart home devices or digital voice assistants.

8 Dec 2021

Rapid antigen detection test for SARS-CoV-2 proves more effective than expected, large study reports

In what is believed to be the largest prospective study of its kind to date - involving some 6,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a 10-day period around the beginning of 2021 - researchers at Johns Hopkins Medicine, the University of Maryland Medical Center, the University of Maryland School of Medicine and four other collaborators report that a rapid antigen detection test for SARS-CoV-2, the virus that causes COVID-19, proved more effective than expected when compared with virus detection rates using the established standard test, the polymerase chain reaction (PCR) assay.

8 Dec 2021

Long COVID-19 in frontline workers found to directly impact health service delivery

New findings show that Long COVID-19 among frontline workers could directly impact health service delivery.

7 Dec 2021

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Our internal 24-hour circadian clock regulates many aspects of physiology, including the response to infectious disease and vaccination.

7 Dec 2021

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Led by computational researchers from WEHI, in collaboration with The University of Queensland, Queensland University of Technology and Hospital Marcelino Champagnat in Brazil, the study used advanced spatial transcriptomic techniques to screen for genes associated with excessive inflammation in the lungs, a key indicator of severe COVID-19.

7 Dec 2021

Cervical cancer screening behaviors differ between vaccinated and unvaccinated women

Women who are vaccinated against human papillomavirus (HPV) are more likely to undergo cervical cancer screenings than unvaccinated women, according to new research by Penn State College of Medicine.

7 Dec 2021

CDC awards $22 million to fight antimicrobial resistance through the launch of two new networks

The Centers for Disease Control and Prevention (CDC) announced today that it has awarded $22 million to nearly 30 organizations around the world to combat antimicrobial resistance (AR) and other healthcare threats through the establishment of two new networks - the Global Action in Healthcare Network (GAIHN) and the Global AR Laboratory and Response Network (Global AR Lab & Response Network).

7 Dec 2021

Health Care News and Research

Prescribing generic heart medications in Medicare Part D could result in substantial savings

Never mind toys, it’s time to ask Santa for crutches and catheters

Health experts worry CDC’s covid vaccination rates appear inflated

COVID-19 led to increased depression and anxiety among urban, ethnic minority children

Abortion remains safe after removing restrictions on the medical abortion pill, study finds

Youths did not seek healthcare both before and during the COVID-19 pandemic

COVID-19 disruptions linked to increase in malaria cases and deaths

New hormone may play a key role in the development of type 1 and type 2 diabetes

Impact of COVID-19 on children with complex underlying medical conditions

Optimizing the treatment of epilepsy patients

Post-pandemic, what’s a phone call from your physician worth?

Oncology doctors say the build back better act will slash cancer care funding — a skewed argument

New projects aim to identify new solutions to combat antimicrobial-resistant infections

Study analyzes the contribution of AI to cancer patient care and vaccine design

Rapid antigen detection test for SARS-CoV-2 proves more effective than expected, large study reports

Long COVID-19 in frontline workers found to directly impact health service delivery

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Cervical cancer screening behaviors differ between vaccinated and unvaccinated women

CDC awards $22 million to fight antimicrobial resistance through the launch of two new networks

Event guide: 3rd Measuring Patient Engagement Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News